Feedback    Advertise    Reprints    About    Help    Contact   
Upstream Processing Downstream Processing Manufacturing Analytical Facilities
Archive by Issue Archive by Article Type Supplements
CMC Forum
April 2010
April 2010, Vol.8 No.4
On the Cover

Scanning electron micrograph of Vero cells cultured on microcarrier beads with Thermo Fisher Scientific media. (www.hyclone.com)

COMPLIANCE
John Avellanet
BioProcess International, Vol. 8, No. 4, April 2010, pp. 10–14
 
Uwe Muegge, CSOFT International
BioProcess International, Vol. 8, No. 4, April 2010, pp. 16–20
Gary Hu
BioProcess International, Vol. 8, No. 4, April 2010, pp. 22–25
 
Shingo Tsuji, Ilham Naili, Nathan R. Authement, Anca M. Segall, Veronica Hernandez, Bryan M. Hancock, Matthew J. Giacalone, Stanley R. Maloy
BioProcess International, Vol. 8, No. 4, April 2010, pp. 28–40
Alejandro Toro, Janet Colon, Victor Melendez-Colon, Jose Hector Rivera
BioProcess International, Vol. 8, No. 4, April 2010, pp. 50–55
Russell E. Madsen, Theodore H. Meltzer, Maik W. Jornitz
BioProcess International, Vol. 8, No. 4, April 2010, pp. 58–64
 
Frank J. Mannuzza, Joseph G. Montalto
BioProcess International, Vol. 8, No. 4, April 2010, pp. 42–48
 
Xiaoguang Liu, Jian Liu, Tasha Williams Wright, Jessica Lee, Peggy Lio, Laurel Donahue-Hjelle, Paula Ravnikar, Florence Wu
BioProcess International, Vol. 8, No. 4, April 2010, pp. 68–76
 
BioProcess International, Vol. 8, No. 4, April 2010, pp. 78–80
 
BioProcess International, Vol. 8, No. 4, April 2010, p. 82
 
Tom Harvath
BioProcess International, Vol. 8, No. 4, April 2010, p. 84
 
The Best of GE Healthcare: Tools for vaccine processes

In vaccine development and manufacturing, GE Healthcare provides a suite of scalable solutions from cell culture through purification to analysis, which offer flexibility and economy, improve purity and secure quality.

Register to download these two NEW application notes:

Microcarriers and disposable bioreactors for MDCK and Vero cell culture
Secure cell propagation with adherent cells at reduced cost and with increased flexibility

DNA removal from influenza virus culture
HTPD and DoE for development and optimization of a chromatography step for the removal of host cell derived genomic DNA


More Travel Tips from the Editor in Chief
Webinars   
Subscribe   
Reprints   
Contact   
About   
Informa plc
©2002 - 2009 BioProcess International
Ph: 508-616-5550